These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 608570)

  • 81. [Prevention of recurrence after successful gallstone dissolution].
    Leiss O; von Bergmann K
    Z Gastroenterol; 1991 Jun; 29(6):301-5. PubMed ID: 1926965
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The UDCA dosage deficit: a fate shared with CDCA.
    Roda E; Liva S; Ferrara F; Azzaroli F; Giovanelli S; Nigro G; Festi D; Mazzella G
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):213-6. PubMed ID: 11953683
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial.
    Leuschner M; Leuschner U; Lazarovici D; Kurtz W; Hellstern A
    Gut; 1988 Apr; 29(4):428-32. PubMed ID: 3286383
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.
    Petroni ML; Jazrawi RP; Grundy A; Lanzini A; Pigozzi MG; Biasio A; Heaton KW; Virjee J; Northfield TC
    Dig Dis Sci; 1995 Sep; 40(9):1956-62. PubMed ID: 7555450
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.
    Ros E; Navarro S; Fernández I; Reixach M; Ribó JM; Rodés J
    Gastroenterology; 1986 Sep; 91(3):703-12. PubMed ID: 3732768
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
    Hirota I; Chijiiwa K; Noshiro H; Nakayama F
    Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Is there a place for medical treatment in children with gallstones?
    Gamba PG; Zancan L; Midrio P; Muraca M; Vilei MT; Talenti E; Guglielmi M
    J Pediatr Surg; 1997 Mar; 32(3):476-8. PubMed ID: 9094022
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Factors affecting gall-stone dissolution rate during chenic acid therapy.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible?
    Iser JH; Murphy GM; Dowling RH
    Gut; 1977 Jan; 18(1):7-15. PubMed ID: 838406
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
    Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
    Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution.
    Ponchon T; Barkun AN; Pujol B; Mestas JL; Lambert R
    Gastroenterology; 1989 Aug; 97(2):457-63. PubMed ID: 2744359
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Incomplete dissolution of calculi. Calcification, cholecystectomy, after treatment of biliary lithiasis with chenodeoxycholic acid].
    Toulet J; Rousselet J; Viteau JM; Duchon Y; Pagniez R; Samain B; Vienne JL
    Gastroenterol Clin Biol; 1983 Dec; 7(12):969-74. PubMed ID: 6662332
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Effect of ursodeoxycholic acid on cholesterol gallstone dissolution (author's transl)].
    Nambu M; Kuroda H; Namihisa T; Ohama H; Maeda M
    Nihon Shokakibyo Gakkai Zasshi; 1978 Nov; 75(11):1768-80. PubMed ID: 731984
    [No Abstract]   [Full Text] [Related]  

  • 96. [Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid].
    Makino I; Shinozaki K; Yoshino K; Nakagawa S
    Nihon Shokakibyo Gakkai Zasshi; 1975 Jun; 72(6):690-702. PubMed ID: 1238741
    [No Abstract]   [Full Text] [Related]  

  • 97. Effect of ursodeoxycholic Acid alone and ursodeoxycholic Acid plus domperidone on radiolucent gallstones and gallbladder contractility in humans.
    Tuncer I; Harman M; Colak Y; Arslan I; Turkdogan MK
    Gastroenterol Res Pract; 2012; 2012():159438. PubMed ID: 22611378
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Probiotics for gallstone prevention in patients with bariatric surgery: A prospective randomized trial.
    Han ML; Lee MH; Lee WJ; Chen SC; Almalki OM; Chen JC; Wu CC
    Asian J Surg; 2022 Dec; 45(12):2664-2669. PubMed ID: 35232647
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Retrospective studies on gallstone disappearance (author's transl)].
    Sugata F; Shimizu M
    Nihon Shokakibyo Gakkai Zasshi; 1974 Jan; 71(1):75-80. PubMed ID: 4859088
    [No Abstract]   [Full Text] [Related]  

  • 100. Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review.
    Tonin F; Arends IWCE
    Beilstein J Org Chem; 2018; 14():470-483. PubMed ID: 29520309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.